Physician profile
Michael A Pell
NPI 1710987128
$2,081.31
in general payments reported to CMS, 2019-2025
8 companies · $678 in 2025
The $678 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $317 · 2020: $241 · 2022: $509 · 2023: $86.43 · 2024: $251 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804 · Travel and Lodging: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.78 |
| Travel and Lodging | $211.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $616.06 | 2022-2025 | O-Arm, Catalyft Pl Expandable Interbody System |
| Globus Medical, INC. | $475.24 | 2024-2025 | Excelsius Gps, Xlif, Elsa |
| Medtronic USA, INC. | $373.46 | 2019-2020 | |
| Depuy Synthes Sales INC. | $261.46 | 2022-2025 | Synfix Evolution, Aegis, Conduit |
| Nuvasive, INC. | $184.56 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $98.49 | 2022 | |
| Sanara Medtech INC. | $47.51 | 2024-2025 | Celleraterx, Celleraterx |
| Clariance, INC. | $24.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.